Abstract
We assessed concentrations of arsenic trioxide (As 2O 3) and its metabolites in the plasma and cerebrospinal fluid in acute promyelocytic leukemia patients who achieved complete remission with intravenous As 2O 3. Arsenic trioxide exists as high molecular mass proteins and low molecular mass proteins in the plasma, and metabolites seem to be able to penetrate blood–brain barrier. Methylarsonic acid (MA) in the cerebrospinal fluid is stably detected and its level was higher than that in plasma after As 2O 3 treatment. Trivalent arsenic (AS III) and dimethylarsinic acid (DMA) became detectable after As 2O 3 infusion, though the levels of arsenic metabolites in the cerebrospinal fluid was lower than plasma levels. Results suggest that a combinatory treatment of As 2O 3 with other chemotherapeutics could be effective for APL patients with CNS involvement.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
